Health Care & Life Sciences » Biotechnology | Neuren Pharmaceuticals Ltd.

Neuren Pharmaceuticals Ltd. | Income Statement

Fiscal year is January-December. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
395.00
100.00
90.00
80.00
78.00
77
Gross Income
395.00
100.00
90.00
80.00
78.00
77
SG&A Expense
11,015.00
12,553.00
17,162.00
15,087.00
6,626.00
8,098
EBIT
-
12,653.00
17,252.00
-
6,704.00
8,175
Unusual Expense
2,685.00
31.00
-
-
9,482.00
3,921
Non Operating Income/Expense
3,441.00
3,807.00
2,771.00
1,121.00
168.00
14,505
Pretax Income
10,470.00
8,316.00
14,146.00
13,858.00
2,657.00
2,627
Income Tax
-
-
749.00
1,844.00
631.00
446
Consolidated Net Income
10,470.00
8,316.00
13,397.00
12,014.00
3,288.00
3,073
Net Income
10,436.00
8,297.00
13,397.00
12,014.00
3,288.00
3,073
Net Income After Extraordinaries
10,436.00
8,297.00
13,397.00
12,014.00
3,288.00
3,073
Net Income Available to Common
10,436.00
8,297.00
13,397.00
12,014.00
3,288.00
3,073
EPS (Basic)
0.17
0.11
0.16
2.84
0.04
0.03
Basic Shares Outstanding
63,061.00
77,624.10
84,018.10
4,233.80
91,960.80
99,038.90
EPS (Diluted)
0.17
0.11
0.16
2.84
0.04
0.03
Diluted Shares Outstanding
63,061.00
77,624.10
84,018.10
4,233.80
93,029.90
99,751.40
EBITDA
11,015.00
12,553.00
17,162.00
15,087.00
6,626.00
8,098
Non-Operating Interest Income
184.00
561.00
335.00
188.00
47.00
218
Minority Interest Expense
34.00
19.00
-
-
-
-

About Neuren Pharmaceuticals

View Profile
Address
697 Burke Road
Camberwell Victoria (VIC) 3124
Australia
Employees -
Website http://www.neurenpharma.com
Updated 07/08/2019
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment and neurodegenerative disorders. The company was founded on December 17, 2001 and is headquartered in Melbourne, Australia. .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.